ScholarIQanswers from OpenAlex

Infliximab in young paediatric IBD patients: it is all about the dosing

PaperCitations, authors & open-access status

Infliximab in young paediatric IBD patients: it is all about the dosing is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Infliximab in young paediatric IBD patients: it is all about the dosing have?

ScholarIQcitation count

Infliximab in young paediatric IBD patients: it is all about the dosing has 88 citations in the OpenAlex counts ScholarIQ stores.

When was Infliximab in young paediatric IBD patients: it is all about the dosing published?

ScholarIQyear

Infliximab in young paediatric IBD patients: it is all about the dosing has 2020 year in the ScholarIQ index.

What is the open-access status of Infliximab in young paediatric IBD patients: it is all about the dosing?

ScholarIQoa status

Infliximab in young paediatric IBD patients: it is all about the dosing has hybrid oa status in the ScholarIQ index.

What is the DOI of Infliximab in young paediatric IBD patients: it is all about the dosing?

ScholarIQdoi

The DOI for Infliximab in young paediatric IBD patients: it is all about the dosing is on the source record.

What is the PMID of Infliximab in young paediatric IBD patients: it is all about the dosing?

ScholarIQpmid

The PMID for Infliximab in young paediatric IBD patients: it is all about the dosing is on the source record.

What is the OpenAlex record for Infliximab in young paediatric IBD patients: it is all about the dosing?

ScholarIQopenalex

The OpenAlex for Infliximab in young paediatric IBD patients: it is all about the dosing is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial